Your browser is no longer supported. Please, upgrade your browser.
SNY Sanofi daily Stock Chart
Index- P/E36.37 EPS (ttm)1.41 Insider Own16.40% Shs Outstand2.50B Perf Week-0.74%
Market Cap128.09B Forward P/E14.72 EPS next Y3.48 Insider Trans0.00% Shs Float2.23B Perf Month2.09%
Income3.54B PEG4.85 EPS next Q0.69 Inst Own7.60% Short Float0.09% Perf Quarter10.19%
Sales41.18B P/S3.11 EPS this Y15.50% Inst Trans0.21% Short Ratio1.14 Perf Half Y22.15%
Book/sh26.25 P/B1.95 EPS next Y6.00% ROA- Target Price55.25 Perf Year21.85%
Cash/sh- P/C- EPS next 5Y7.50% ROE- 52W Range40.00 - 51.84 Perf YTD2.07%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-1.16% Beta0.64
Dividend %3.40% Quick Ratio- Sales past 5Y2.70% Gross Margin68.40% 52W Low28.10% ATR0.61
Employees104226 Current Ratio- Sales Q/Q1.80% Oper. Margin12.60% RSI (14)61.08 Volatility0.84% 0.83%
OptionableYes Debt/Eq- EPS Q/Q-18.40% Profit Margin10.70% Rel Volume0.56 Prev Close51.19
ShortableYes LT Debt/Eq- EarningsFeb 06 BMO Payout0.00% Avg Volume1.81M Price51.24
Recom1.40 SMA200.90% SMA505.91% SMA20015.01% Volume1,015,585 Change0.10%
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Jan-17-20 06:00PM  Cancer-fighting Peninsula biotech targets $100M IPO American City Business Journals
05:40PM  Pharma and Biotech Arent Worried About Democratic Candidates Attacks Against Drugmakers
Jan-16-20 09:52AM  Novavax Rises on Fast Track Designation to Influenza Vaccine Zacks
Jan-15-20 10:18AM  Lilly to Launch Cheaper Versions of Humalog KwikPen Insulins Zacks
Jan-14-20 10:03AM  Emergent (EBS) Posts Preliminary '19 Results, Gives 2020 View Zacks
Jan-13-20 12:12PM  Sanofi CFO on Growth Strategy, Valuation, Cost Cuts Bloomberg
09:08AM  Lilly to Buy Dermira for $1.1B, Add Phase III Eczema Candidate Zacks
Jan-10-20 05:00PM  Regeneron's Phase II Candidate Promising in Primary Analysis Zacks
11:51AM  3 Biotech Stocks to Bank on for Buyouts in 2020 InvestorPlace
09:50AM  Lilly Says Its Buying a Biotech With a Dermatitis Drug. Investors Have Other Ideas.
07:13AM  The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx Benzinga
Jan-09-20 04:38PM  Hedge Fund Consensus Stocks vs. Sanofi (SNY) In 2019 Insider Monkey
Jan-08-20 11:25AM  The Zacks Analyst Blog Highlights: JPMorgan, Sanofi, General Electric, American Electric Power and Shopify Zacks
08:13AM  3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 Zacks
Jan-07-20 03:18PM  Facing criticism over insulin prices, drugmakers launch affordability options MarketWatch
02:44PM  Top Stock Reports for JPMorgan, Sanofi & General Electric Zacks
07:57AM  The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering Benzinga
Jan-06-20 04:13PM  One Analyst Thinks AbbVie Is Grossly Undervalued
10:21AM  Buy Sanofi Stock Because Its Undervalued, J.P. Morgan Says
Jan-03-20 09:41AM  Amicus Progresses on Pipeline Development Amid Competition Zacks
Dec-31-19 04:02PM  Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs Reuters
03:59PM  Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs Reuters
Dec-24-19 01:09PM  Why A Bidding War For Synthorx Bodes Well For This Biotech Stock Investor's Business Daily
12:15PM  Biotech Leading in Q4: Best ETFs & Stocks Zacks
07:30AM  10 Biotech M&A Targets Under The Scanner For 2020 Benzinga
Dec-17-19 07:55AM  Sanofi Wins Prestigious Drug Discovery Award for Innovative Rare Blood Clotting Disorder Treatment[1] PR Newswire
Dec-16-19 01:43PM  Amarins fish-oil pill now available to millions more patients. But its still no Lipitor MarketWatch
12:25PM  Euphoria Over a Fish-Oil Heart Pill Hits a Wall Bloomberg
08:38AM  Amarin Gains on FDA Approval of Vascepa Label Expansion Zacks
Dec-14-19 02:37AM  Should You Be Concerned About Sanofi's (EPA:SAN) ROE? Simply Wall St.
Dec-13-19 08:01AM  Pharma Stock Roundup: MRK, SNY to Buy Cancer Firms, LLY Starts New Lung Cancer Study Zacks
05:00AM  Paul Hudson seeks to write new prescription for Sanofi Financial Times
Dec-12-19 11:03AM  The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America Zacks
Dec-11-19 04:16PM  Why Merck, Sanofi News Helped This Biotech Rocket 32% Over Three Days Investor's Business Daily
02:15PM  Top Research Reports for Novartis, AbbVie & Sanofi Zacks
09:14AM  Sanofi, Regeneron to Amend Agreement for Kevzara & Praulent Zacks
08:30AM  Sanofi (SNY) Looks Good: Stock Adds 6.2% in Session Zacks
07:21AM  The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga
05:29AM  Sanofi to restructure Newton diabetes startup Onduo, saying it 'over-invested' American City Business Journals
Dec-10-19 04:16PM  Why Biotech ETFs are Surging to New Highs Zacks +6.16%
04:08PM  Why This Pharmaceutical Stock Broke Out Bullishly In Early Action Investor's Business Daily
12:28PM  Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug Collaborations Benzinga
10:10AM  Biotech ETFs Hit New Highs on Deal Activities Zacks
09:42AM  Merck to Buy ArQule for $2.7B to Boost Cancer Portfolio Zacks
09:03AM  Regeneron shares fall on Sanofi's new direction MarketWatch
08:55AM  Sanofi Unveils Growth Strategy, Ends Diabetes & CV Research Zacks
08:27AM  Pharma M&As Continue, Merck, Sanofi to Buy Cancer Drug Firms Zacks
08:06AM  Dow Jones Futures: Stock Market, Apple On China Trade War Watch; Boeing, MongoDB, Stitch Fix Move On News Investor's Business Daily
07:56AM  The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares Benzinga
07:47AM  Regeneron Stock Slides as French Drug Giant Sanofi Mulls Selling Stake
07:14AM  Drug manufacturers have spent a record $342 billion on M&A in 2019 MarketWatch
06:38AM  Sanofis CEO Quits Diabetes as Cancer Breakthroughs Beckon Bloomberg
05:34AM  European stocks drop for seventh time in nine sessions MarketWatch
04:15AM  UPDATE 1-European shares dip on trade uncertainty Reuters
Dec-09-19 06:49PM  Flagging French Drug Giant Tries a Familiar Remedy Bloomberg
04:45PM  U.S. stock market snaps 3-day win streak as China tariff deadline comes in focus MarketWatch
04:44PM  Sanofis New CEO Is Aiming for a Narrower Focus in Drug Development
04:26PM  UPDATE 2-Sanofi ends research in diabetes, narrows units to spur profit Reuters
04:23PM  Sanofi ends research in diabetes, narrows units to spur profit Reuters
01:08PM  PreMarket Prep Recap: Small Biotech Firms Looking Healthy, Street Fades Macy's Downgrade Benzinga
12:35PM  M&A Monday in healthcare: Merck, Sanofi, UnitedHealth Reuters Videos
11:04AM  Heres the hard-money call for why the boom in the economy and stock market will continue MarketWatch
10:44AM  Drug Giants Pay Hefty Premiums as Cancer-Drug Race Heats Up Bloomberg
10:16AM  Week Begins with Biotech Mergers Zacks
10:06AM  Merger Monday, Biotech Edition: MRK, SNY, ARQL, THOR & More Zacks
09:42AM  Merck and Sanofi Are Both Acquiring Cancer-Drug Developers
09:28AM  Sanofi to Buy Synthorx for $2.5B to Boost Cancer Portfolio Zacks
08:42AM  No News Is Bad News for the Dow on Monday Morning
08:30AM  Sanofi awarded $226 million by US government to expand pandemic influenza preparedness PR Newswire
07:53AM  Synthorx To Be Acquired By Sanofi For $2.5B Benzinga
07:43AM  Sanofi and Merck each buy cancer-focused biotechs Financial Times
07:06AM  Sanofi to Buy U.S. Biotech Firm for $2.5 Billion in Cancer Push Bloomberg
05:30AM  European stocks struggle, with drugmakers weaker and Tullow Oil plunging MarketWatch
05:06AM  Sanofi's New CEO Readies Rx Plan For Pharma Giant Meredith Videos
04:48AM  Sanofi to Buy Synthorx for $2.5 Billion Bloomberg
04:07AM  Sanofi to acquire Synthorx for $2.5 billion MarketWatch
03:52AM  France's Sanofi to buy biotech firm Synthorx for $2.5 billion Reuters
03:11AM  UPDATE 2-France's Sanofi to buy biotech firm Synthorx for $2.5 bln Reuters
01:38AM  France's Sanofi to buy Synthorx for $2.5 billion Reuters
01:38AM  France's Sanofi to buy biotech firm Synthorx for $2.5 billion Reuters
01:32AM  France's Sanofi to buy Synthorx for $2.5 bln Reuters
Dec-06-19 10:23AM  Not Much Chemistry Between Sanofi (SNY) and Hedge Funds Insider Monkey
09:21AM  Regeneron Reports Positive Data on Rare Blood Disorder Drug Zacks
Dec-04-19 04:43PM  Najarian Brothers Highlight Unusual Option Activity In Sanofi, JetBlue And More Benzinga
Dec-02-19 10:39AM  Sanofi agrees to sell Seprafilm to Baxter for $350 million Reuters
07:42AM  REFILE-UPDATE 1-Sanofi agrees to sell Seprafilm to Baxter for $350 mln Reuters
07:00AM  Heart Drugs Are Having a Moment Bloomberg
Nov-29-19 09:34AM  Alnylam Gets Second Product Approval Amid Stiff Competition Zacks
Nov-28-19 07:09AM  Esperion's Promising Drugs Under Review, Funds a Concern Zacks
Nov-26-19 02:07PM  Consumers File Class-Action Lawsuit Against Makers of Zantac, According to Consumer-Rights Law Firm FeganScott Business Wire
07:19AM  Novartis Securities Investment Ltd -- Moody's affirms Novartis' A1 rating; stable outlook Moody's
Nov-25-19 03:45PM  14 Most Shorted European Stocks Benzinga
10:24AM  Novartis (NVS) to Acquire The Medicines Company for $9.7B Zacks
08:24AM  Pfizer Has 5 Drugs in Its Pipeline That Could Turn Its Stock Around
Nov-22-19 10:29AM  AI Sirona (Luxembourg) Acquisition S.a.r.l. -- Moody's affirms Zentiva's B3 CFR; outlook stable Moody's
07:13AM  Exclusive: Sanofi's strategy boss to leave as CEO readies revamp Reuters
06:42AM  Exclusive: Sanofi's strategy boss to leave as CEO readies revamp Reuters
Nov-21-19 02:39PM  AI Sirona (Luxembourg) Acquisition S.a.r.l. -- Moody's affirms Zentiva's B3 CFR; outlook stable Moody's
11:12AM  Sanofi Is Said to Mull Options for $30 Billion Consumer Arm Bloomberg
09:15AM  Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session PR Newswire
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has an alliance with Verily Life Sciences LLC; and agreement with Happify Health. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerSep 10Sale281.15172,90448,611,80420,550,813Sep 12 05:00 PM
Sanofi10% OwnerJul 22Buy16.0093,7501,500,000558,035Jul 23 11:39 AM
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM